Boston Common Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $16M | Sell |
|
|||||
|
2025
Q2 | $20.5M | Sell |
|
|||||
|
2025
Q1 | $24.7M | Buy |
|
|||||
|
2024
Q4 | $20.3M | Buy |
|
|||||
|
2024
Q3 | $23.4M | Buy |
|
|||||
|
2024
Q2 | $17.5M | Sell |
|
|||||
|
2024
Q1 | $16.4M | Sell |
|
|||||
|
2023
Q4 | $22.5M | Sell |
|
|||||
|
2023
Q3 | $20.2M | Sell |
|
|||||
|
2023
Q2 | $20.8M | Sell |
|
|||||
|
2023
Q1 | $23.5M | Sell |
|
|||||
|
2022
Q4 | $22.3M | Buy |
|
|||||
|
2022
Q3 | $21.8M | Buy |
|
|||||
|
2022
Q2 | $15.5M | Buy |
|
|||||
|
2022
Q1 | $8.32M | Buy |
|
|||||
|
2021
Q4 | $6.82M | Sell |
|
|||||
|
2021
Q3 | $5.72M | Sell |
|
|||||
|
2021
Q2 | $6.39M | Buy |
|
|||||
|
2021
Q1 | $5.17M | Buy |
|